Albemarle (ALB) 8-K Other Events

Exhibit 99.2

FIVE-YEAR SUMMARY
(In Thousands, Except for Per Share Amounts and Footnote Data)
Year Ended December 31	2013			2012			2011			2010			2009
Results of Operations
Net sales	$	2,394,270		$	2,519,154		$	2,651,667		$	2,170,500		$	1,843,878
Costs and expenses	1,817,595			2,119,371			2,131,919			1,779,266			1,700,344
Operating profit	576,675			399,783			519,748			391,234			143,534
Interest and financing expenses	(31,559		)	(32,800		)	(37,574		)	(25,533		)	(24,584		)
Other (expenses) income, net	(6,674		)	1,229			357			2,788			(1,423		)
Income from continuing operations before income taxes and equity in net income of unconsolidated investments	538,442			368,212			482,531			368,489			117,527
Income tax expense (benefit)	134,445			80,433			104,471			84,183			(21,364		)
Income from continuing operations before equity in net income of unconsolidated investments	403,997			287,779			378,060			284,306			138,891
Equity in net income of unconsolidated investments (net of tax)	31,729			38,067			43,754			37,975			22,322
Income (loss) from continuing operations	435,726			325,846			421,814			322,281			161,213
Income (loss) from discontinued operations (net of tax)	4,108			4,281			(1,617		)	7,136			8,812
Net income	439,834			330,127			420,197			329,417			170,025
Net income attributable to noncontrolling interests	(26,663		)	(18,591		)	(28,083		)	(13,639		)	(11,255		)
Net income attributable to Albemarle Corporation	$	413,171		$	311,536		$	392,114		$	315,778		$	158,770
Financial Position and Other Data
Total assets	$	3,584,797		$	3,437,291		$	3,203,824		$	3,068,081		$	2,771,557
Operations:
Working capital	$	1,046,552		$	1,022,304		$	954,442		$	984,021		$	678,823
Current ratio	3.40			3.66			3.38			3.70			2.92
Depreciation and amortization	$	107,370		$	99,020		$	96,753		$	95,578		$	100,513
Capital expenditures	$	155,346		$	280,873		$	190,574		$	75,478		$	100,786
Investments in joint ventures	$	—		$	—		$	10,868		$	1,333		$	—
Acquisitions, net of cash acquired	$	2,565		$	3,360		$	13,164		$	11,978		$	4,017
Research and development expenses	$	82,246		$	78,919		$	77,083		$	58,394		$	60,918
Gross profit as a % of net sales	35.5			35.7			35.9			33.5			24.8
Total long-term debt	$	1,078,864		$	699,288		$	763,673		$	860,910		$	812,713
Total equity(a)	$	1,742,776		$	1,932,008		$	1,678,827		$	1,475,746		$	1,253,318
Total long-term debt as a % of total capitalization	38.2			26.6			31.3			36.8			39.3
Net debt as a % of total capitalization(b)	25.2			9.6			13.9			17.1			27.6
Common Stock
Basic earnings per share
Continuing operations	$	4.88		$	3.44		$	4.35		$	3.38		$	1.64
Discontinued operations	$	0.05		$	0.05		$	(0.02	)	$	0.08		$	0.09

Shares used to compute basic earnings per share	83,839			89,189			90,522			91,393			91,512
Diluted earnings per share
Continuing operations	$	4.85		$	3.42		$	4.30		$	3.35		$	1.63
Discontinued operations	$	0.05		$	0.05		$	(0.02	)	$	0.08		$	0.09
Shares used to compute diluted earnings per share	84,322			89,884			91,522			92,184			92,046
Cash dividends declared per share	$	0.96		$	0.80		$	0.67		$	0.56		$	0.50
Total equity per share(a)	$	21.77		$	21.73		$	18.90		$	16.11		$	13.70
Return on average total equity	22.5		%	17.3		%	24.9		%	23.1		%	13.4		%

Footnotes:

(a) Equity reflects the repurchase of common shares amounting to: 2013—9,198,056; 2012—1,092,767; 2011—3,000,000; 2010—400,356 and 2009—174,900.

(b) We define net debt as total debt plus the portion of outstanding joint venture indebtedness guaranteed by us (or less the portion of outstanding joint venture indebtedness consolidated but not guaranteed by us), less cash and cash equivalents.